Press releases
Prime Therapeutics Debuts its MedSelect™ Medical Drug List
MedSelect leverages Prime’s novel medical drug management strategy to drive appropriate use of medical benefit drugs, cost effectiveness and better health outcomes
October 27, 2020“Our primary goal is to help our members get the medicine they need to optimize their health,” said Joseph Leach, M.D., senior vice president and chief medical officer for Prime. “There are a growing number of specialty drugs that are covered by the medical insurance benefit, which is why we’ve expanded our approach to ensure we encourage the use of therapies that bring the most value to our members under the medical benefit.”
The MedSelect drug list includes drugs based on clinical efficacy and/or superiority as well as cost-effectiveness which can provide members with access to medical drugs that may lead to improved health outcomes. The drug list steers clients toward a drug in certain therapeutic categories that meets the factors mentioned above. MedSelect uses utilization management and site of care opportunities that seek to achieve savings and appropriate medical drug use. It’s expected that MedSelect will help enable Blue Plans to achieve a 4-7% reduction in medical drug cost through cost avoidance.
MedSelect will offer both managed and highly managed strategies. MedSelect – Managed follows strategies that are more flexible and allow for more drug choice options; while MedSelect – Highly Managed follows strategies that are more selective and geared toward the lowest net-cost options. MedSelect is the latest offering in Prime’s suite of total drug management tools.
Related news
Press releases
September 21, 2023
Prime Therapeutics Appoints New Chief Compliance Officer
EAGAN, Minn. – Prime Therapeutics LLC/Magellan Rx, a pharmacy benefit manager (PBM) serving…
Press releases
September 18, 2023
Prime Therapeutics and Magellan Rx enhance specialty pharmacy patient experience with Inovalon’s ScriptMed® SaaS Solution
Eagan, Minn. and Bowie, Md. – Sept. 18, 2023 – Prime Therapeutics LLC…
Press releases
August 28, 2023
Magellan Rx Pharmacy LLC earns URAC Reaccreditation
EAGAN, Minn. – Prime Therapeutics LLC (Prime)/Magellan Rx (MRx) is proud to announce…